Description
The Bremelanotide 8.75mg Pen is a single disposable, prefilled pen containing 8.75 mg of bremelanotide in total.
Pricing
- 1 to 4 pens: $80 each
- 5 to 9 pens: $60 each
- 10 or more pens: $40 each
Ordering
A valid prescription is required. Every order is reviewed by our partner pharmacy before it is dispatched, and you will receive an email once it is approved. Payment is by cryptocurrency or cash on delivery.
Use only as directed by your prescribing doctor.
Clinical trial results: bremelanotide
Bremelanotide (Vyleesi) is FDA-approved only for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women, as a 1.75 mg on-demand injection. It is not a weight-loss medicine and has not been studied for weight loss. The 8.75 mg pen sold on this page is not the approved presentation.
| Trial | Population (n) | Dose / duration | Main result vs placebo | Source |
|---|---|---|---|---|
| RECONNECT (Obstet Gynecol 2019) | Premenopausal women with HSDD (two phase 3 trials, about 1,267 randomised) | 1.75 mg as needed, 24 weeks | Endpoints were desire and distress scores, not weight. Bremelanotide improved both co-primary endpoints vs placebo. | Kingsberg et al., DOI 10.1097/AOG.0000000000003500 |
Common side effects reported in trials
- FDA label: nausea 40% vs 1.3% placebo; flushing 20.3% vs 1.3%; headache 11.3% vs 1.9%.
- Transient increases in blood pressure after dosing are listed in the label warnings: Vyleesi prescribing information (DailyMed).
Individual results differ and results vary. Figures above are group averages from the cited studies, not a prediction for any individual. This summary is for information only and is not medical advice; speak to a licensed healthcare professional.
Frequently asked questions
Is bremelanotide a weight-loss drug?
No. Its only FDA approval is for HSDD in premenopausal women, and it has not been studied for weight loss.
What are the most common side effects?
In the FDA label, nausea was reported by 40% vs 1.3% on placebo, flushing by 20.3% and headache by 11.3%.
Reviews
There are no reviews yet.